Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension

M. Barros (Santiago, Chile), M. Fonseca (Santiago, Chile), M. Henriquez (Santiago, Chile)

Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Session: Pulmonary hypertension in lung diseases and the role of the right ventricle
Session type: Thematic Poster
Number: 3115
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Barros (Santiago, Chile), M. Fonseca (Santiago, Chile), M. Henriquez (Santiago, Chile). Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension. 3115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010


Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008



Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 704-713
Year: 2014



Intra-breath CO-diffusion and pulmonary blood flow at rest and during exercise in pulmonary arterial hypertension and pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 403s
Year: 2004

Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

Endothelium in pulmonary arterial hypertension
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Impact of cyanosis on ventilatory kinetics during stairclimbing in pulmonary arterial hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1483-1485
Year: 2010


Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021



The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Year: 2018



Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003



Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017


Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=397
Year: 2007

Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=126
Year: 2005

Pulmonary arterial hypertension
Source: Breathe 2010; 6: 377-380
Year: 2010

Pulmonary arterial hypertension
Source: Eur Respir Monogr 2014; 66: 232-246
Year: 2014


Pulmonary arterial hypertension
Source: Eur Respir Monogr 2013; 62: 70-84
Year: 2013


Pulmonary arterial hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Elevated pulmonary capillary pressure in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001

Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009